The Gut-Brain Axis: Digestive Support with CBG and CBC
Minor cannabinoids offer a targeted approach to digestive health that differs from the baseline effects of standard CBD. Cannabigerol (CBG) and Cannabichromene (CBC) interact with the enteric nervous system and may support the body in addressing inflammation, cramping, and intestinal permeability. By understanding how these compounds influence your physical state, you can integrate them into a daily recovery routine with precision.
By Genevieve
The Vagus Nerve: The Brain-Gut Highway
The Vagus nerve acts as the primary physical transit route connecting your emotional centers to your digestive tract. When you experience "butterflies" or stress-induced nausea, that is often the Vagus nerve firing. Low Vagus tone is a factor associated with sluggish digestion, inflammation, and GI distress.
CBD increases levels of anandamide—a neurotransmitter that stimulates the Vagus nerve—which may help shift your body into a "rest and digest" state. Many report a release of tension in the chest and abdomen. Start with a conservative dose of 10–15mg to gauge your system's response without overstimulating your receptors.
CBG vs. CBC: Targeted Inflammation Support
While both compounds are considered anti-inflammatory, they serve distinct roles in digestive recovery.
CBG: The Tissue Support
CBG functions as support for gut tissue. It targets PPAR-gamma receptors, which are responsible for influencing inflammatory gene expression in the colon.
- Best For: Supporting recovery from physical tissue damage or inflammatory flares.
- The Sensation: CBG may feel grounding and stable. It can help reduce the "heat" and localized pressure often associated with an inflammatory flare.
- Data: Research suggests CBG may help normalize colon weight during inflammation, which is a factor in physical recovery.
CBC: The Pain Modulator
CBC specializes in pain management and intestinal integrity. It interacts with TRP channels to dampen the sharp, stabbing pain signals originating in the gut.
- Best For: Deep cramping and managing symptoms of "Leaky Gut."
- The Sensation: CBC may offer relief from the discomfort of intestinal hypermotility (rapid, painful contractions) without the constipation often associated with over-the-counter anti-diarrheal medications.
- Data: CBC may help reinforce the "tight junctions" of the gut lining, which helps prevent undigested food particles from passing into the bloodstream.
The Raw Advantage: CBDA and CBGA for Nausea
Raw, unheated cannabinoids are often bioavailable for the digestive tract. CBDA (Cannabidiolic Acid) may be effective at managing nausea because it interacts with 5-HT1A receptors, which regulate serotonin levels in the gut. CBGA (Cannabigerolic Acid) provides similar anti-inflammatory benefits to CBG but is processed efficiently by the gut before it reaches the liver. When shopping, look for "cold-pressed" or "raw" tinctures to ensure you are obtaining these acidic forms.
Metabolic Regulators: THCV and Humulene
Digestive wellness involves maintaining metabolic rhythm. Specific minor compounds may influence appetite and metabolic signals.
- THCV (The Satiety Signal): At low doses, THCV acts as a CB1 receptor antagonist. It may suppress appetite and support insulin sensitivity, which is helpful for those managing metabolic-related gut inflammation.
- Humulene: This terpene, found in hops and various cannabis strains, works with THCV to help curb the urge to overeat. Use Humulene-rich products before meals to encourage mindful eating and prevent the bloating that accompanies overconsumption.
Microbiome Signaling and Short-Chain Fatty Acids
Your endocannabinoid system (ECS) communicates with gut bacteria, specifically in regulating Akkermansia muciniphila—the bacteria that maintains your protective mucus layer.
Cannabinoids like CBD and CBG may encourage the production of Short-Chain Fatty Acids (SCFAs) like butyrate. These acids serve as a fuel source for colon cells. By increasing SCFA production through cannabinoid use, you may provide your gut with the energy it needs to support its own lining and seal the gaps associated with "Leaky Gut."
The Restorative Protocol: A Daily Implementation
To get the most out of these compounds, match them to your body’s natural rhythms:
- Morning (Barrier Support): Use a CBDA/CBGA raw tincture. This may settle the Vagus nerve and protect the gut lining before your first meal. Take 5–10mg sublingually and hold for at least 60 seconds.
- Mid-Day (Metabolic Balance): Use a product high in THCV and CBC. This may manage mid-day cramping while keeping blood sugar stable and curbing inflammatory food cravings.
- Evening (Deep Repair): Use a high-CBG oil paired with Beta-Caryophyllene. This combination focuses on colon tissue repair and muscle relaxation, supporting the gut's "night shift" recovery processes while you sleep.
Give your body three days to respond to each dose before making adjustments. These minor cannabinoids are potent; finding your "minimum effective dose" is the recommended way to ensure long-term progress without desensitizing your receptors.
Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.
Sources
-
Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Clouse RE, Izzo AA. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol. 85(9):1306-16. PubMed
-
De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY, Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T. (2011). Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 6(12):e28159. PubMed
-
Izzo AA, Sharkey KA. (2010). Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 126(1):21-38. PubMed
-
Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio MG, Pertwee RG, Coppola D, Vassallo L, Orlando P, Di Marzo V, Izzo AA. (2013). The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol. 169(1):213-29. PubMed
Ready to find your strain?
Add your strains, pick your effects — we'll rank them.